The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgery

Javanmard, Shaghayegh Haghjooy; Heshmat-Ghahdarijani, Kiyan; Mirmohammad-Sadeghi, Mohsen; Sonbolestan, Sayed Ali; Ziayi, Amin

The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgery

Document Type : Original Article

Authors

¹ Department of Physiology, Physiology Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Cardiac Surgery, Isfahan Medical School, Isfahan University of Medical Sciences, Isfahan, Iran

³ Medical Student Research Center, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: In this study, we investigated the effect of melatonin administration on four markers of endothelial cell function including intercellular adhesion molecule (ICAM), vascular cell adhesion molecule (VCAM), C-reactive protein (CRP), and nitric oxide (NO) on patients with three vessels coronary disease.
Materials and Methods: This double-blind, randomized, controlled trial study was conducted on 39 patients (32 men and 7 women) with three vessels coronary disease. The case group included 20 patients who received 10 mg oral melatonin 1 h before sleeping for 1 month. The control group included 19 patients who received placebo 1 h before sleeping for 1 month. The serum levels of CRP, ICAM, VCAM, and NO were compared after 1 month treatment.
Results: After 1 month of melatonin treatment, the mean level of ICAM, VCAM, and CRP showed a statistically significant decrease in the case group. On the other hand, the mean level of VCAM increased significantly in the control group. The mean levels of CRP and ICAM were also increased in the control group, but the difference did not reach the significant threshold. With respect to NO, there was a statistically significant increase in the case group, while there was a statistically significant decrease in serum NO in the control group.
Conclusions: The results of this study suggested that melatonin may have beneficial effects on endothelial oxidative stress even in patient with severe and advanced atherosclerosis.

Keywords

References

1.	Ruff CT, Braunwald E. The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol 2011;8:140-7.
2.	Haghjooyjavanmard S, Nematbakhsh M, Monajemi A, Soleimani M. Von Willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemia in rabbit. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008;152:91-5.
3.	Alian Z, Hashemipour M, Dehkordi EH, Hovsepian S, Amini M, Moadab MH, et al. The effects of folic acid on markers of endothelial function in patients with type 1 diabetes mellitus. Med Arh 2012;66:12-5.
4.	Yang Z, Ming XF. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res 2006;4:53-65.
5.	Cuzzocrea S, Mazzon E, Serraino I, Lepore V, Terranova ML, Ciccolo A, et al. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis. J Pineal Res 2001;30:1-12.
6.	Beck WR, Botezelli JD, Pauli JR, Ropelle ER, Gobatto CA. Melatonin has an ergogenic effect but does not prevent inflammation and damage in exhaustive exercise. Sci Rep 2015;5:18065.
7.	Altun A, Yaprak M, Aktoz M, Vardar A, Betul UA, Ozbay G. Impaired nocturnal synthesis of melatonin in patients with cardiac syndrome X. Neurosci Lett 2002;327:143-5.
8.	Domínguez-Rodríguez A, Abreu-González P, García MJ, Sanchez J, Marrero F, de Armas-Trujillo D. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 2002;33:248-52.
9.	Yaprak M, Altun A, Vardar A, Aktoz M, Ciftci S, Ozbay G. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int J Cardiol 2003;89:103-7.
10.	Rodella LF, Favero G, Foglio E, Rossini C, Castrezzati S, Lonati C, et al. Vascular endothelial cells and dysfunctions: Role of melatonin. Front Biosci (Elite Ed) 2013;5:119-29.
11.	Tutuncu NB, Batur MK, Yildirir A, Tutuncu T, Deger A, Koray Z, et al. Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy. J Pineal Res 2005;39:43-9.
12.	Simko F, Paulis L. Melatonin as a potential antihypertensive treatment. J Pineal Res 2007;42:319-22.
13.	Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009;73:411-8.
14.	Marçola M, da Silveira Cruz-Machado S, Fernandes PA, Monteiro AW, Markus RP, Tamura EK. Endothelial cell adhesiveness is a function of environmental lighting and melatonin level. J Pineal Res 2013;54:162-9.
15.	Tailleux A, Gozzo A, Torpier G, Martin-Nizard F, Bonnefont-Rousselot D, Lemdani M, et al. Increased susceptibility of low-density lipoprotein to ex vivo oxidation in mice transgenic for human apolipoprotein B treated with 1 melatonin-related compound is not associated with atherosclerosis progression. J Cardiovasc Pharmacol 2005;46:241-9.
16.	Tailleux A, Torpier G, Bonnefont-Rousselot D, Lestavel S, Lemdani M, Caudeville B, et al. Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta. Biochem Biophys Res Commun 2002;293:1114-23.

Advanced Biomedical Research